Scott Thomas Jackson Insider Profile
4 Followers
Scott Thomas Jackson, Director at Spero Therapeutics, holds 85.00K shares in Spero Therapeutics (Ticker: SPRO), holds ― shares in Mural Oncology Plc (Ticker: MURA), holds 14.75K shares in MacroGenics (Ticker: MGNX).
Scott Thomas Jackson Spero Therapeutics (SPRO)Director
Spero Therapeutics (SPRO)
Director
Not Ranked
Ranked #40,916 out of 108,921 Corporate Insiders
Scott Thomas Jackson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Thomas Jackson holds in companies
Most Profitable Insider Trade
Stock:
Celator Pharmaceuticals
(CLPM)
(CLPM)
Rating:Informative Buy
Date:Nov 18, 2014 - Nov 18, 2015
Return:-18.90%
The most profitable trade made by Scott Thomas Jackson
Scott Thomas Jackson's Trading History
Spero Therapeutics
Jun 25, 2026
Director
Uninformative Buy
―
$102.85K
Mural Oncology Plc
―
―
―
―
Celator Pharmaceuticals
Jul 12, 2016
―
Uninformative Sell
9.12M
$3.03M
MacroGenics
May 20, 2026
Director
Uninformative Buy
16.31K
$64.90K
Crescent Biopharma
May 27, 2021
Director
Uninformative Buy
―
$109.62K
List of latest transactions for each holding click on a transaction to see Scott Thomas Jackson's performance on stock
You May Also Like
Scott Thomas Jackson insider profile FAQ
What is the percentage of profitable transactions made by Scott Thomas Jackson?
The percentage of profitable transactions made by Scott Thomas Jackson is ―.
What is the average return per transaction made by Scott Thomas Jackson?
The average return per transaction made by Scott Thomas Jackson is ―.
What stocks does Scott Thomas Jackson hold?
Scott Thomas Jackson holds: SPRO, MURA, CLPM, MGNX, CBIO stocks.
What was Scott Thomas Jackson’s latest transaction?
Scott Thomas Jackson latest transaction was an Uninformative Buy of ―.
What was Scott Thomas Jackson's most profitable transaction?
Scott Thomas Jackson’s most profitable transaction was an Informative Buy of CLPM stock on November 18, 2014. The return on the trade was -18.90%.
What is Scott Thomas Jackson's role in Spero Therapeutics?
Scott Thomas Jackson's role in Spero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.